ID: h-96795760
Hypothesis
H3K9me3 Heterochromatin Loss at Pericentromeric Repeats
H3K9me3 Heterochromatin Loss at Pericentromeric Repeats.
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 2 oppose
⚠ Thin Description Senate Quality Gates →
🧪 Overview
H3K9me3 Heterochromatin Loss at Pericentromeric Repeats
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["H3K9me3 Heterochromatin<br/>Hypothesis Target"]
B["Pathway Dysregulation<br/>Cited Mechanism"]
C["Cellular Response<br/>Stress or Clearance Change"]
D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
E["Neurodegeneration<br/>Disease-Relevant Outcome"]
A --> B
B --> C
C --> D
D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix5 supports2 contradicts
Supports
Suv39h-catalyzed H3K9me3 is critical for euchromatic genome organization and the maintenance of gene transcription.
Supports
The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells.
Supports
HP1 proteins regulate nucleolar structure and function by secluding pericentromeric constitutive heterochromatin.
Supports
Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability.
Supports
Toxic Y chromosome: Increased repeat expression and age-associated heterochromatin loss in male Drosophila with a young Y chromosome.
Contradicts
Heterochromatin relaxation is a broad aging and disease concept, but review-level evidence does not establish H3K9me3 pericentromeric loss as a specific neurodegenerative mechanism.
Contradicts
Therapeutic work around H3K9 methyltransferase G9a is mainly framed for neuropsychiatric disorders, so extension to neurodegeneration remains indirect.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — H3K9ME3
No curated PDB or AlphaFold mapping for H3K9ME3 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for H3K9me3 Heterochromatin.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0070
Events (7d)
3
Price History
▼5.2%💾 Resource Usage
LLM Tokens
36,950
$0.1109
Total Cost
$0.1109
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF Drosophila expressing human α-synuclein (UAS-αSyn) under pan-neuronal driver are crossed with Setdb1 overexpression line (UAS-Setdb1) to achieve co-expression, THEN median survival will increase by | H3K9me3 levels at Drosophila pericentromeric satellite repeats (determined by ChIP-qPCR) will be maintained at near-wildtype levels (≤20% reduction from control | — no observation — | pending | 0.55 |
| IF primary cortical neurons from aged (>18 months) C57BL/6 mice are treated with SIRT1 inhibitor EX-527 (100 μM, 48h), THEN H3K9me3 enrichment at major satellite repeats (measured by ChIP-qPCR with pr | ≥50% reduction in H3K9me3 at pericentromeric repeats, accompanied by ≥2-fold increase in major satellite transcript levels (qRT-PCR) and ≥1.5-fold elevation in | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF primary cortical neurons from aged (>18 months) C57BL/6 mice are treated with SIRT1 inhibitor EX-527 (100 μM, 48h), THEN H3K9me3 enrichment at major satellite repeats (measured by ChIP-qPCR with primers: 5'-GGGAAAAANTGGGAATGG-3') will decrease by >50% compared to vehicle-treated controls.
Predicted outcome: ≥50% reduction in H3K9me3 at pericentromeric repeats, accompanied by ≥2-fold increase in major satellite transcript levels (qRT-PCR) and ≥1.5-fold ele
Falsification: No significant change in H3K9me3 at pericentromeric repeats (<20% decrease) or no elevation in interferon response genes (Ifnb1, Cxcl10) after SIRT1 inhibition would falsify the mechanistic link.
pendingconf 55%
IF Drosophila expressing human α-synuclein (UAS-αSyn) under pan-neuronal driver are crossed with Setdb1 overexpression line (UAS-Setdb1) to achieve co-expression, THEN median survival will increase by ≥30% and climbing ability at day 21 will be ≥40% better compared to α-synuclein-expressing siblings
Predicted outcome: H3K9me3 levels at Drosophila pericentromeric satellite repeats (determined by ChIP-qPCR) will be maintained at near-wildtype levels (≤20% reduction fr
Falsification: Setdb1 overexpression failing to increase survival by ≥30% or maintain H3K9me3 levels at pericentromeric repeats would falsify the protective role of heterochromatin restoration in synucleinopathy mod
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.